Spread The Word
DESCRIPTION A non-interventional, longitudinal study in people with FOP designed to:

  • Understand the relationship between new bone formation in FOP and clinical measures of physical function and quality of life
  • Monitor disease progression over time
ELIGIBILITY CRITERIA
  • Clinical diagnosis of FOP (Ages 0 to 65)
DESIGN
  • Study will prospectively follow up to 100 people with FOP for up to 3 years
  • Thorough baseline (at beginning of study) examination conducted to determine the current status of disease
  • Participants evaluated annually, with more frequent visits if they experience a flare-up
CLINICALTRIALS.GOV IDENTIFIER: NCT02322255
TRIAL ID NUMBER PVO-1A-001
CONTACT CLEMENTIA Please contact our call center:
US/Canada: +1-800-750-8710
Italy: 800-879-880
Spain: 900-838-561
UK: 0-808-189-3399
Email Us: ClinicalTrials@clementiapharma.com
Natural History Study Information (PDF)

Donna Grogan, Chief Medical Officer at Clementia, answers questions from the FOP disease community about the Natural History Study.